H. E. Kaiser

539 citations
20 papers · 426 indexed · h-index 12

H. E. Kaiser

20 papers receiving 412 citations

Peers

H. E. Kaiser
Comparison fields: 5 of 61
  • Endocrinology, Diabetes and Metabolism 87
  • Oncology 116
  • Immunology and Allergy 25
  • Cancer Research 55
  • Hepatology 23
Replace N E Heldin with:
N E Heldin Sweden
Laura Bald United States
Sweta Sudhir United States
Annika Hermansson Sweden
Nicolas Wisniacki United Kingdom
Kiyoshi Shingū Japan
Stephanie J. McAlhany United States
Mareina Kudo Japan
Anne M. Vrabel United States
Sarah L. McCarron Ireland
H. E. Kaiser relative to N E Heldin Sweden N E Heldin's profile →
Citations per field
00.5×
N E Heldin · 1×
Citations per year

Countries citing papers authored by H. E. Kaiser

Since Specialization
Citations

This map shows the geographic impact of H. E. Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. E. Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. E. Kaiser more than expected).

Fields of papers citing papers by H. E. Kaiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. E. Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. E. Kaiser. The network helps show where H. E. Kaiser may publish in the future.

Co-authorship network

The 25 scholars most cited alongside H. E. Kaiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. E. Kaiser Line = papers co-authored together H. E. Kaiser links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1
Development of Organotypic Cancer Models for the Identification of Individualized Cancer Therapies
20162
2 200610
3
Value of multilevel sectioning for improved detection of micrometastases in sentinel lymph nodes in invasive squamous cell carcinoma of the vulva.
200419
4
Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
20017
5 200149
6
Papillary microcarcinoma of the thyroid: a clinico-pathologic and prognostic review.
200036
7
Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in childhood medulloblastomas/primitive neuroectodermal tumors.
200030
8
Novel insights into the function of the thymic Hassall's bodies.
200035
9
Colonic type adenocarcinoma of male urethra.
20001
10
Apoptosis and pathogenesis of viral hepatitis C--an update.
200034
11
Controversies on the prognostic significance of tumor infiltrating leukocytes in solid human tumors.
200013
12
Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy.
199832
13
Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma.
199846
14
Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas.
199757
15
Advances in the understanding of lung cancer.
19976
16
Development of Hassall's bodies of the thymus in humans and other vertebrates (especially mammals) under physiological and pathological conditions: immunocytochemical, electronmicroscopic and in vitro observations.
199722
17
Immunohistochemical detection of p53 protein expression in various childhood astrocytoma subtypes: significance in tumor progression.
19976
18
Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.
19975
19
Identification of neural crest derived cells within the cellular microenvironment of the human thymus employing a library of monoclonal antibodies raised against neuronal tissues.
199615
20 19891

About H. E. Kaiser

H. E. Kaiser is a scholar working on Neurology, Oncology, Cancer Research, Genetics and Urology, having authored 20 papers that have together received 426 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (4 papers), Hedgehog Signaling Pathway Studies (2 papers), Glioma Diagnosis and Treatment (2 papers), Microtubule and mitosis dynamics (2 papers), Cancer Genomics and Diagnostics (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (87 citations), Oncology (116 citations), Immunology and Allergy (25 citations), Cancer Research (55 citations) and Hepatology (23 citations). H. E. Kaiser has collaborated with scholars based in United States, Austria and Italy. Frequent co-authors include B Bödey, Stuart E. Siegel, N. Neuhold, Klaus Kaserer, A M Gröger, Arwa Nasir, C R Taylor, James V. Luck, Aqsa Nasir and Jennifer Z. Gillespie. Their work appears in journals such as Journal of Clinical Oncology, Endocrine Pathology, RWTH Publications (RWTH Aachen) and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026